Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

Ortivus has successfully been qualified for the NHS Framework Agreement covering MobiMed Life, opening new possibilities in the United Kingdom

Ortivus
Download udgivelse

We are pleased to announce that Ortivus’ tender application for MobiMed Life has been approved by the NHS Supply Chain and that the company thereby has been selected for participation in the NHS Framework Agreement to provide External Defibrillation Devices and Related Services and Accessories. This is an important step forward for Ortivus on the UK market as all care units connected to the NHS can call-off defibrillators from the entire MobiMed Life range. The framework duration is 4 years from the Commencement Date. As the framework is used to streamline the procurement process for the end customer, being on the framework has no defined order value at this point but may lead to future orders based on the agreement.

The National Health Service (NHS) is an organisation that provides member trusts and publicly funded bodies with strategic purchasing support. That Ortivus has been qualified for this NHS Framework Agreement means that the company’s solutions have been evaluated and approved and that Ambulance Trusts, care units and hospitals across the United Kingdom can call-off Ortivus’ MobiMed Life, from automatic external defibrillators to advanced manual defibrillators.

“To be qualified for the NHS Framework Agreement is an important step in the right direction for Ortivus’ further expansion on the UK-market. We look forward to the possibility of delivering MobiMed Life to care units all over the United Kingdom.” – Says Elias Obaid, Ortivus’ Sales Manager.

Ortivus are one of several competing suppliers that have qualified for the framework. A mandatory minimum 10 calendar day standstill period applies before NHS Supply Chain can conclude this Framework Agreement. Subject to the satisfactory conclusion of the standstill period, the framework agreement will be concluded at midnight on Tuesday 2nd May 2023.

Contacts


For further information, please contact

Reidar Gårdebäck, CEO

Telefon +46 8 446 45 00

About Ortivus


Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.

MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in real-time, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.

MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.
 
Read more about Ortivus at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-04-24 15:15 CEST.

Attachments


Ortivus has successfully been qualified for the NHS Framework Agreement covering MobiMed Life, opening new possibilities in the United Kingdom

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.